Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo

David J. Matthews, F. Michael Yakes, Jason Chen, Michele Tadano, Lester Bornheim, Douglas O. Clary, Albert Tai, Jill M. Wagner, Nicole Miller, Yong D. Kim, Scott Robertson, Louis Murray, Larry M. Karnitz

Research output: Contribution to journalArticlepeer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences